Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Arend

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
Bulletin on the Rheumatic Diseases|January 1, 1992
Receptor-targeted immunotherapyR W Janson, W P Arend
Cytokine|September 1, 1991
Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cellsW P Arend, B P Coll
Arthritis and Rheumatism|February 2, 2008
The development of anticytokine therapeutics for rheumatic diseasesWilliam P Arend, Mary B Goldring
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1977
Catabolism and biologic properties of two species of rat IgG2a Fc fragmentsS P Arend, D E Webster
Immunology|December 1, 1981
The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytesW P Arend, R J Massoni
The Journal of Experimental Medicine|January 1, 1980
Loss of Fc receptor activity after culture of human monocytes on surface-bound immune complexes. Mediation by cyclic nucleotidesC G Ragsdale, W P Arend
Revue Medicale De Bruxelles|January 1, 1995
[Rupture of an abdominal aortic aneurysm in a nonagenarian]P Arend, C Goffin, B Bellens
JAMA|June 18, 1997
RheumatologyR S Panush, W P Arend
Nature Reviews. Rheumatology|August 22, 2012
Pre-rheumatoid arthritis: predisposition and transition to clinical synovitisWilliam P Arend, Gary S Firestein
Annals of the Rheumatic Diseases|October 29, 2000
Biological role of interleukin 1 receptor antagonist isoformsW P Arend, C J Guthridge
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Bulletin on the Rheumatic Diseases|January 1, 1992
Receptor-targeted immunotherapyR W Janson, W P Arend
Cytokine|September 1, 1991
Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cellsW P Arend, B P Coll
Arthritis and Rheumatism|February 2, 2008
The development of anticytokine therapeutics for rheumatic diseasesWilliam P Arend, Mary B Goldring
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1977
Catabolism and biologic properties of two species of rat IgG2a Fc fragmentsS P Arend, D E Webster
Immunology|December 1, 1981
The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytesW P Arend, R J Massoni
The Journal of Experimental Medicine|January 1, 1980
Loss of Fc receptor activity after culture of human monocytes on surface-bound immune complexes. Mediation by cyclic nucleotidesC G Ragsdale, W P Arend
Revue Medicale De Bruxelles|January 1, 1995
[Rupture of an abdominal aortic aneurysm in a nonagenarian]P Arend, C Goffin, B Bellens
JAMA|June 18, 1997
RheumatologyR S Panush, W P Arend
Nature Reviews. Rheumatology|August 22, 2012
Pre-rheumatoid arthritis: predisposition and transition to clinical synovitisWilliam P Arend, Gary S Firestein
Annals of the Rheumatic Diseases|October 29, 2000
Biological role of interleukin 1 receptor antagonist isoformsW P Arend, C J Guthridge
Pageof 17